HIV Citation List: October 1- October 14, 2010
Pubmed citations:
1. Three new water-soluble alkaloids from the leaves of suregada glomerulata (Blume) Baill. Yan, R.Y., H.Q. Wang, C. Liu, R.Y. Chen, and D.Q. Yu, Fitoterapia, 2010; PMID[20940031].
[Pubmed]. HIV_1001-101410.
2. In Vitro Antioxidant Properties, HIV-1 Reverse Transcriptase and Acetylcholinesterase Inhibitory Effects of Traditional Herbal Preparations Sold in South Africa. Ndhlala, A.R., J.F. Finnie, and J. Van Staden, Molecules, 2010. 15(10): p. 6888-6904; PMID[20938401].
[Pubmed]. HIV_1001-101410.
3. A gyrase B inhibitor impairs HIV-1 replication by targeting HSP90 and the capsid protein. Vozzolo, L., B. Loh, P.J. Gane, M. Tribak, L. Zhou, I. Anderson, E. Nyakatura, R.G. Jenner, D. Selwood, and A. Fassati, Journal of Biological Chemistry, 2010; PMID[20937817].
[Pubmed]. HIV_1001-101410.
4. Resistance profiles of novel electrostatically constrained HIV-1 fusion inhibitors. Shimura, K., D. Nameki, K. Kajiwara, K. Watanabe, Y. Sakagami, S. Oishi, N. Fujii, M. Matsuoka, S.G. Sarafianos, and E. Kodama. Journal of Biological Chemistry, 2010; PMID[20937812].
[Pubmed]. HIV_1001-101410.
5. Novel compounds containing multiple guanide groups which bind the HIV co-receptor CXCR4. Wilkinson, R.A., S.H. Pincus, J.B. Shepard, S.K. Walton, E.P. Bergin, M. Labib, and M. Teintze. Antimicrobial Agents and Chemotherapy, 2010; PMID[20937786].
[Pubmed]. HIV_1001-101410.
6. Complete Inactivation of HIV-1 Using Photo-Labeled Non-Nucleoside Reverse Transcriptase Inhibitors. Rios, A., J. Quesada, D. Anderson, A. Goldstein, T. Fossum, S. Colby-Germinario, and M.A. Wainberg, Virus Research, 2010; PMID[20937333].
[Pubmed]. HIV_1001-101410.
7. Toward the First Nonpeptidic Molecular Tong Inhibitor of Wild-Type and Mutated HIV-1 Protease Dimerization. Vidu, A., L. Dufau, L. Bannwarth, J.L. Soulier, S. Sicsic, U. Piarulli, M. Reboud-Ravaux, and S. Ongeri. ChemMedChem, 2010; PMID[20936621].
[Pubmed]. HIV_1001-101410.
8. Design and synthesis of dually branched 5'-norcarbocyclic adenosine phosphonodiester analogue as a new anti-HIV prodrug. Oh, C.H., L.J. Liu, and J.H. Hong. Nucleosides Nucleotides & Nucleic Acids, 2010. 29(10): p. 721-33; PMID[20924954].
[Pubmed]. HIV_1001-101410.
ISI Web of Knowledge citations:
9. Quinoline-based compounds as modulators of HIV transcription through NF-kappa B and Sp1 inhibition. Bedoya, L.M., M.J. Abad, E. Calonge, L.A. Saavedra, M. Gutierrez, V.V. Kouznetsov, J. Alcami, and P. Bermejo. Antiviral Research, 2010 87(3): p. 338-344.
[WOS]. HIV_1001-101410.
10. Isolation, Sequencing, and Structure-Activity Relationships of Cyclotides. Ireland, D.C., R.J. Clark, N.L. Daly, and D.J. Craik. Journal of Natural Products, 2010. 73(9): p. 1610-1622.
[Pubmed]. HIV_1001-101410.
11. Metabolism and pharmacokinetics of GS-8374: A novel phosphonate-containing HIV protease inhibitor with high barrier to resistance. Mollova, N., J. Tang, C. Bramwell-German, E.I. Lepist, N. Chu, W. Chen, B. Wong, P. Staehr, and K.H. Leung. Drug Metabolism Reviews, 2009. 41(S3): p. 131-132.
[WOS]. HIV_1001-101410.
12. A review on the isolation and structure of tea polysaccharides and their bioactivities. Nie, S.P. and M.Y. Xie. Food Hydrocolloids, 2010. 25(2): p. 144-149.
[WOS]. HIV_1001-101410.
13. Synthesis and microbial studies of (4-oxo-thiazolidinyl) sulfonamides bearing quinazolin-4(3h)ones. Patel, N.B., V.N. Patel, H.R. Patel, F.M. Shaikh, and J.C. Patel. Acta Poloniae Pharmaceutica, 2010. 67(3): p. 267-275.
[WOS]. HIV_1001-101410.
14. Synthesis and antiviral evaluation of alpha-D-2 ',3 '-didehydro-2 ',3 '-dideoxy-3 '-C-hydroxymethyl nucleosides. Yamada, K., H. Hayakawa, S. Sakata, N. Ashida, and Y. Yoshimura. Bioorganic & Medicinal Chemistry Letters, 2010. 20(20): p. 6013-6016.
[WOS]. HIV_1001-101410.